4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000950170-24-018175
General Counsel and Secretary sold 1,913 shares at $79.67 ($152,409)
- General Counsel and Secretary acquired 3,825 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KASINGER JAMES R. General Counsel and Secretary | 2024-02-18 | Option exercise | +3,825 | 59,284 | D | ||
| KASINGER JAMES R. General Counsel and Secretary | 2024-02-20 | Sale | −1,913 | $79.67 | $152,409 | 57,371 | D |
| Derivatives | |||||||
| KASINGER JAMES R. General Counsel and Secretary | 2024-02-18 | Option exercise · Restricted Stock Units | −3,825 | 7,650 | D | ||
| Open-market sales · 1,913 sh · avg $79.67 · $152,409 | |||||||
Loading xslF345X05/ownership.xml…